HNB
VERA icon

Huntington National Bank’s Vera Therapeutics VERA Stock Holding History

Huntington National Bank’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$20.7K Sell
515
-135
-21% -$5.82K ﹤0.01% 1640
2025
Q4 		$32.9K Sell
650
-135
-17% -$4.79K ﹤0.01% 1408
2025
Q3 		$22.8K Sell
785
-15
-2% -$347 ﹤0.01% 1554
2025
Q2 		$18.8K Buy
800
+1
+0.1% +$22 ﹤0.01% 1598
2025
Q1 		$19.2K Buy
799
+184
+30% +$5.91K ﹤0.01% 1531
2024
Q4 		$26K Buy
+615
New +$27.2K ﹤0.01% 1461

Other funds holding VERA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Huntington National Bank's VERA Position: Q1 2026 in Review

Huntington National Bank reduced its Vera Therapeutics (VERA) stake by 21% in Q1 2026, selling an estimated $5.82K and leaving 515 shares worth $20.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1640.

Huntington National Bank first reported a position in VERA in Q4 2024 and has held it in 6 quarters since. The position peaked at $32.9K in Q4 2025. 229 funds tracked by Wall St. Rank hold VERA as of Q1 2026.

  • Huntington National Bank held 515 shares of Vera Therapeutics worth $20.7K as of Q1 2026.
  • Huntington National Bank sold 135 Vera Therapeutics shares in Q1 2026, an estimated $5.82K.
  • Vera Therapeutics made up ﹤0.01% of Huntington National Bank's portfolio in Q1 2026, its #1640 holding.
  • Huntington National Bank first reported a position in Vera Therapeutics in Q4 2024 and has held it in 6 quarters since.
  • Huntington National Bank's Vera Therapeutics position peaked at $32.9K in Q4 2025.
  • 229 funds tracked by Wall St. Rank held Vera Therapeutics as of Q1 2026.

Based on Huntington National Bank's 13F filing for Q1 2026, filed 15 May 2026.